Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers asa BMP delivery system for inducing bone

Citation
N. Saito et al., Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers asa BMP delivery system for inducing bone, J BONE-AM V, 83A, 2001, pp. S92-S98
Citations number
30
Categorie Soggetti
Ortopedics, Rehabilitation & Sport Medicine","da verificare
Journal title
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
ISSN journal
00219355 → ACNP
Volume
83A
Year of publication
2001
Part
2
Supplement
1
Pages
S92 - S98
Database
ISI
SICI code
0021-9355(2001)83A:<S92:BPAGBC>2.0.ZU;2-V
Abstract
Background: Bone morphogenetic proteins (BMPs) are biologically active mole cules capable of eliciting new bone formation. In combination with biomater ials, these proteins can be used in a clinical setting as bone-graft substi tutes to promote bone repair. Collagen from animal sources has previously b een the preferred carrier material in animal experiments. More recently, sy nthetic biodegradable polymers have been tested as a delivery vehicle for o steoinductive agents. In earlier studies performed in our laboratory, it wa s found that the polylactic acid homopolymers (PLA650) and poly-D,L-lactic acid-polyethylene glycol block copolymers (PLA650-PEG200) are viscous liqui ds that can be used as BMP delivery systems. Methods: To obtain new PLA-PEG polymers that exhibit greater plasticity, th e molecular sizes of PLA and PEG segments in the copolymer chains were incr eased. Plastic PLA-PEG polymers with various molecular sizes and PLA/PEG ra tios were synthesized, mixed with recombinant human (rh) BMP-2, and implant ed into the dorsal muscles of mice for 3 weeks to evaluate their capacity t o elicit new bone formation. To compare the plastic PLA-PEG polymer with th e liquid PLA650-PEG200 polymer, these two polymers were combined with rhBMP -2, implanted, and harvested after 3 weeks. Bone mineral content (BMC), bon e area, and bone mineral density (BMD) of the ectopic new bone were measure d by means of single energy X-ray absorptiometry (SXA). Results: All of the PLA6,500-PEG3,000 implants with 10 or 20 mug of rhBMP-2 showed new bone formation. In contrast, little or no bone formation was se en in other plastic PLA-PEG implants with rhBMP-2. Control implants that la cked rhBMP-2 did not show new bone formation. Radiographic and histologic e xaminations showed that the PLA6,500-PEG3,000 implants with rhBMP-2 harvest ed 3 weeks after implantation had normal bone characteristics with hematopo ietic marrow and osseous trabeculae. SXA analysis showed that the values fo r bone mineral content (BMC), bone area, and bone mineral density (BMD) of new bone resulting from the use of plastic PLA6,500-PEG3,000 polymers with rhBMP-2 were significantly higher than those obtained with the liquid PLA65 0-PEG200 polymers (p < 0.001 for each of the three values). Conclusions: These results indicate that the PLA6,500-PEG3000 block copolym er with plastic properties works effectively as a BMP delivery system. Thes e data suggest that the total molecular size and ratio of PLA size to PEG s ize is an essential factor in determining the efficacy of a BMP delivery sy stem. After implantation, it is possible that the PLA6,500-PEG3,000 pellets might have absorbed tissue fluids and become swollen, resulting in bone fo rmation that exceeded the size of the original implants. This expansion cha racteristic is a potentially beneficial property, given the intended practi cal application of the polymer in the repair of bone defects. Conclusions: These results indicate that the PLA6,500-PEG3000 block copolym er with plastic properties works effectively as a BMP delivery system. Thes e data suggest that the total molecular size and ratio of PLA size to PEG s ize is an essential factor in determining the efficacy of a BMP delivery sy stem. After implantation, it is possible that the PLA6,500-PEG3,000 pellets might have absorbed tissue fluids and become swollen, resulting in bone fo rmation that exceeded the size of the original implants. This expansion cha racteristic is a potentially beneficial property, given the intended practi cal application of the polymer in the repair of bone defects. Clinical Relevance: New synthetic biodegradable delivery systems will play an important role in the clinical applications of rhBMPs in which local for mation of bone via an osteoinductive graft material is needed. Further pre- clinical and clinical work is necessary to establish the safety of these im plants before they are adopted for widespread clinical use.